Author(s): Virani Paras, Virani Kinjal

Email(s): parasvirani@gmail.com ,

DOI: 10.5958/2231-5691.2016.00007.1   

Address: Virani Paras1*, Virani Kinjal2
1Research Scholar 2014, Gujarat Technological University, Gujarat
2Quality assurance department, Shree Dhanvantary Pharmacy College, Kim, Surat
*Corresponding Author

Published In:   Volume - 6,      Issue - 1,     Year - 2016


ABSTRACT:
Hypertension and Hypercholesterolemia are a major public health problem in the developed Countries in recently Hypertension and hypercholesterolemia are frequently treated with antihypertensive drugs like calcium-channels blockers, angiotensin-converting enzyme inhibitors, and angiotensin II type 1 (AT1) receptor blockers, and statins. Irbesartan is Angiotensin II receptor type 1 antagonist and widely used in treatment of hypertension condition. Atorvastatin is HMG CoA reductase inhibitor and widely used in treatment of hyperlipidaemias condition. Combination of irbesartan and atorvastatin is used to treatment of cardiovascular diseases like hypertension and hyperlipidemias, so this combination therapy gives antihypertensive and antilipidemic treatment for condition of coronary artery diseases.


Cite this article:
Virani Paras, Virani Kinjal. A Review on Irbesartan Co-administered with Atorvastatin for the Treatment of Cardiac Risk. Asian J. Pharm. Res. 6(1): January -March, 2016; Page 39-44. doi: 10.5958/2231-5691.2016.00007.1


Recomonded Articles:

Author(s): Akhil Gupta, Anuj Mittal , Alok Kumar Gupta

DOI:         Access: Open Access Read More

Author(s): Vidya Raju, Jasmine Joy Bell, Merlin. N. J, Shaiju S. Dharan

DOI: 10.5958/2231-5691.2017.00033.8         Access: Open Access Read More

Author(s): Prabhu Venkatesh Moodbidri, Varadaraji Dhayanithi, Ganesh Belavadi Manjunathashastry, Hari Narayan Pati , Pardhasaradhi Vasireddy

DOI: 10.5958/2231-5691.2015.00027.1         Access: Open Access Read More

Author(s): Prathap Kumar Kothapalli, Jagadeesh. S. Sanganal, N.B. Shridhar

DOI:         Access: Open Access Read More

Author(s): Girish Pai K., Vamshi Krishna T., Lalit Kumar, M. Sreenivasa Reddy, G. Shreenidhi, A. Praneeth Reddy

DOI:         Access: Open Access Read More

Author(s): Kishan L. Jadhav, Priyanka R. Kapare, Divya V. Khairmode, Chaitali H. Keskar1, Farida Shaikh, Shradda Sawant, Akash S. Mali

DOI: 10.5958/2231-5691.2018.00031.X         Access: Open Access Read More

Author(s): Indu Sharma, Bharat Parashar, Hitesh Kumar Dhamija , Ritu sharma

DOI:         Access: Open Access Read More

Author(s): Jude Chigozie Ikewuchi, Catherine Chidinma Ikewuchi and Mercy Onuekwuzu Ifeanacho

DOI:         Access: Open Access Read More

Author(s): Mohd. Yaqub Khan, Poonam Gupta, Bipin Bihari, Vikas Kumar Verma

DOI:         Access: Open Access Read More

Author(s): K.Prathyusha, M.Venkataswamy, K.Sridivya Goud, M.Rani, G.Sai Sruthi, K.Priyanka

DOI: 10.5958/2231-5691.2018.00044.8         Access: Closed Access Read More

Author(s): Ikewuchi Jude C.1*, Ikewuchi Catherine C.1, Ifeanacho Mercy O.1, Igboh Ngozi M.2, Enuneku Emeke C.1 and Osayande Osazee I.1

DOI:         Access: Open Access Read More

Author(s): Betsy Joseph, Anuradha V. P, Jayakrishnan S. S, Ajith B

DOI: 10.5958/2231-5691.2019.00027.3         Access: Closed Access Read More

Author(s): Shailesh H. Lunkad, Surajj Sarode

DOI: 10.5958/2231-5691.2019.00037.6         Access: Closed Access Read More

Author(s): Kamisetti R Rajeswari, Vinitha Brungi, S. Bennuru, Sr. Cheeli, RM. Gupta Vankadari

DOI: 10.5958/2231-5691.2020.00001.5         Access: Closed Access Read More

Author(s): Suraj V. Bondre, Rushikesh S. Chavan, Indrayani D. Raut, Shrinivas K. Mohite, Chandrakant S. Magdum

DOI: 10.5958/2231-5691.2020.00028.3         Access: Closed Access Read More

Asian Journal of Pharmaceutical Research (AJPRes.) is an international, peer-reviewed journal, devoted to pharmaceutical sciences. AJPRes. publishes Original Research Articles, Short Communications..... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231–5691 


Recent Articles




Tags